United States · FDA National Drug Code directory
Safyral
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-403_e2c77609-66d5-4e76-8f2b-060c9e30b5e9
- Product NDC
- 50419-403
- Form
- KIT
- Composition / generic term
- Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20120213
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 90 BLISTER PACK in 1 PACKAGE (50419-403-00) / 1 KIT in 1 BLISTER PACK · 50419-403-00
- 3 BLISTER PACK in 1 PACKAGE (50419-403-03) / 1 KIT in 1 BLISTER PACK (50419-403-01) · 50419-403-03
- 90 BLISTER PACK in 1 PACKAGE (50419-403-70) / 1 KIT in 1 BLISTER PACK · 50419-403-70
- 12 PACKAGE in 1 CARTON (50419-403-75) / 5 BLISTER PACK in 1 PACKAGE / 1 KIT in 1 BLISTER PACK (50419-403-71) · 50419-403-75
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →